Double Pigtail Ureteral Stent Market Size, Sales, Average Price and Trends Analysis, till 2032

Double Pigtail Ureteral Stent Market Size is estimated to be $390 million in 2024 and is expected to grow at an average yearly rate of around 5.3% during the timeframe (2025-2032).

Monitor Country-wise Double Pigtail Ureteral Stent Sales and Demand with Our Comprehensive Double Pigtail Ureteral Stent Sales Database

Gain in-depth insights into the Double Pigtail Ureteral Stent Sales landscape across United States, Germany, France, UK and 20+ countries with our specialized Double Pigtail Ureteral Stent Sales Database. Stay ahead in the market by tracking country-wise Double Pigtail Ureteral Stent Sales, identifying key manufacturers.

Extensive Double Pigtail Ureteral Stent Sales database covering United States, Germany, France, UK and 20+ countries worldwide, Double Pigtail Ureteral Stent Sales trends

Double Pigtail Ureteral Stent market revenue tracker by country: United States, Germany, France, UK and 20+ countries worldwide

Stay Updated with Double Pigtail Ureteral Stent Sales Trends

Track real-time Double Pigtail Ureteral Stent prices, analyze Double Pigtail Ureteral Stent price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Double Pigtail Ureteral Stent Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/double-pigtail-ureteral-stent-market/



Double Pigtail Ureteral Stent sales trend in 2024 vs 2025

The market for double pigtail ureteral stents has shown a noticeable upward trend from 2024 to 2025, reflecting growing demand driven by multiple healthcare factors. These stents, widely used in urology to ensure proper urine flow from the kidney to the bladder, are essential in treating various urinary tract conditions. Understanding the sales trend involves examining key drivers such as medical advancements, patient demographics, and healthcare practices.

In 2024, sales of double pigtail ureteral stents were robust, with steady growth supported by increasing cases of kidney-related ailments like kidney stones and urinary obstructions. The rising incidence of such conditions, partly due to lifestyle changes and aging populations worldwide, boosted the need for stent placement. The ureteral stent market during this period experienced moderate growth, fueled by both demand in developed regions with advanced healthcare systems and emerging markets with expanding medical infrastructure.

Moving into 2025, this growth accelerated noticeably. One major factor behind the increase in sales is the ongoing innovation in stent design and materials. Improvements such as biocompatible coatings, enhanced flexibility, and the development of stents that reduce patient discomfort have made these devices more attractive to healthcare providers and patients alike. These advancements not only improve clinical outcomes but also reduce complications related to stent use, such as encrustation and infection, thus encouraging wider adoption.

Additionally, the shift towards minimally invasive urological procedures has contributed significantly to the sales growth in 2025. Double pigtail stents are a critical component in many such interventions, as they help manage urine flow during and after surgeries involving the urinary tract. The preference for less invasive techniques, which lead to faster recovery times and lower hospital stays, has led to increased use of these stents.

Demographically, the global aging population plays a crucial role. As life expectancy rises, so does the prevalence of urological disorders commonly associated with older age. Conditions such as benign prostatic hyperplasia and recurrent kidney stones are more frequent in elderly patients, thus driving demand for ureteral stents. This demographic trend has been consistent over both years but became more pronounced in 2025 due to increased awareness and better diagnostic capabilities.

Geographically, regions with well-established healthcare systems, including North America and parts of Europe, continue to dominate sales. However, emerging economies in Asia-Pacific and Latin America have shown substantial market growth, contributing to the overall rise in global sales figures. Investments in healthcare infrastructure, increased access to diagnostic tools, and expanding urology specialty services in these regions have fueled market expansion.

Despite the positive trend, certain challenges remain. Stent-related complications still pose concerns, affecting patient comfort and treatment outcomes, which can sometimes limit repeat usage. Furthermore, the cost of advanced stent technology can be a barrier in lower-income regions, slowing penetration despite growing demand.



Request for customization https://datavagyanik.com/reports/double-pigtail-ureteral-stent-market/



Double Pigtail Ureteral Stent Market Definition

The double pigtail ureteral stent market refers to the commercial and healthcare sector focused on the manufacturing, distribution, and sale of double pigtail ureteral stents. These medical devices are small, flexible tubes inserted into the ureter-the duct that carries urine from the kidney to the bladder-to maintain patency and ensure continuous urine flow. The design features two curled ends (or "pigtails") that anchor the stent securely inside the kidney and bladder, preventing migration and minimizing discomfort.

Double pigtail ureteral stents serve an essential role in urology by addressing urinary obstructions caused by various conditions such as kidney stones, tumors, strictures, and post-surgical swelling. When the natural passage for urine is blocked or narrowed, these stents help restore normal flow, reduce pain, and prevent kidney damage or infection. Their widespread clinical use has made them a critical component in modern urological care.

The market itself encompasses multiple stakeholders, including medical device manufacturers, distributors, healthcare providers, and end-users such as hospitals and specialized clinics. Manufacturers design stents with various materials like polyurethane, silicone, or biodegradable polymers, incorporating features aimed at improving patient comfort and reducing complications. These include coatings to resist encrustation, drug-eluting surfaces, and customizable lengths or diameters to suit different patient needs.

Demand in the double pigtail ureteral stent market is driven largely by the increasing prevalence of urological disorders globally. Conditions such as kidney stones have become more common due to lifestyle changes, dietary habits, and aging populations. Additionally, rising rates of urinary tract infections and cancers affecting the urinary tract further increase the necessity for these stents. As healthcare providers seek effective, minimally invasive solutions, double pigtail stents have gained preference due to their ease of placement and effectiveness.

Technological advancements also significantly influence market dynamics. Innovations focus on improving the material composition to enhance biocompatibility, reduce irritation, and extend stent dwell time without complications. Recent developments include biodegradable stents that dissolve after their purpose is fulfilled, eliminating the need for removal procedures. Additionally, coatings that minimize bacterial adhesion and encrustation help reduce infection risks and improve patient outcomes.

Geographically, the market is segmented by region, with well-established healthcare infrastructure in North America and Europe leading sales due to higher awareness and access to advanced medical care. However, rapid healthcare development in Asia-Pacific and Latin America is driving faster growth in these regions, supported by rising healthcare expenditures and improving diagnostic capabilities.

The double pigtail ureteral stent market faces challenges including patient discomfort during stent placement and dwelling, potential complications such as infection or migration, and the need for repeated procedures. Furthermore, cost and accessibility remain barriers in developing regions, limiting widespread adoption despite rising demand.

Important target segments driving the demand for Double Pigtail Ureteral Stent Market

The demand for double pigtail ureteral stents is influenced by several key target segments within the healthcare ecosystem. Understanding these segments is crucial for grasping the market dynamics and the factors driving growth. These segments are defined by patient demographics, medical conditions, healthcare settings, and geographic regions that collectively shape the demand patterns for these stents.

1. Patient Segments

The primary target group for double pigtail ureteral stents includes patients suffering from urological conditions that cause urinary obstruction or require temporary urinary drainage. This group mainly comprises:

Kidney Stone Patients: Kidney stones are one of the most common causes of urinary blockage, leading to severe pain and kidney damage if untreated. Patients undergoing procedures like lithotripsy or ureteroscopy often require stent placement to ensure urine flow during recovery.

Patients with Urinary Tract Obstruction: Conditions such as ureteral strictures, tumors, or external compression of the ureter require stent insertion to maintain urine passage. This segment includes both benign and malignant cases.

Post-Surgical Patients: After surgeries involving the urinary tract or surrounding organs, stents are frequently used to prevent blockage caused by swelling or scarring during healing.

Patients with Chronic Urological Disorders: Those with recurrent urinary tract infections or benign prostatic hyperplasia may require stents periodically to manage symptoms and prevent complications.

This patient base drives continuous demand due to the prevalence of these conditions across various age groups, particularly among the elderly, who have a higher risk of urological issues.

2. Healthcare Provider Segments

The demand is also shaped by different healthcare settings and professionals:

Hospitals and Surgical Centers: These institutions are major consumers of double pigtail ureteral stents, as they perform the majority of urological surgeries and procedures requiring stent placement.

Specialized Urology Clinics: With the rise of outpatient care, many specialized clinics now handle diagnostic and interventional urological procedures, further expanding the demand outside traditional hospital environments.

Emergency Care Units: In cases of acute urinary obstruction, emergency departments utilize stents for immediate relief, contributing to demand spikes.

3. Technological and Product Segments

Innovations in stent design and materials influence demand by targeting specific clinical needs:

Biodegradable and Drug-Eluting Stents: These advanced stents appeal to patients and clinicians looking to reduce complications and avoid additional procedures for stent removal.

Coated Stents: Designed to minimize encrustation and infection, these products attract segments concerned with long-term stent placement and patient comfort.

4. Geographic Segments

Geographical regions play a significant role in shaping market demand:

Developed Regions: North America and Europe are major markets due to advanced healthcare infrastructure, higher incidence reporting, and greater patient awareness.

Emerging Markets: Asia-Pacific, Latin America, and parts of the Middle East and Africa are witnessing rapid growth driven by improving healthcare facilities, rising incomes, and increasing prevalence of urological disorders.

5. Age and Gender Segments

Elderly Population: Aging increases the risk of conditions such as benign prostatic hyperplasia and kidney stones, making older adults a critical target segment.

Male Population: Certain urological disorders, including prostate-related conditions, predominantly affect men, contributing to higher demand in this demographic.



Key Players in Double Pigtail Ureteral Stent, Market Share: United States and global market

The double pigtail ureteral stent market is an important segment within the medical device industry, focused on supplying specialized stents used in urology to treat urinary tract obstructions. This market is marked by the presence of several key players who dominate both the United States and global landscapes through innovation, strong distribution networks, and regulatory compliance.

In the United States, the market is led by a handful of prominent companies that have established strong reputations for quality and reliability. Boston Scientific Corporation is one of the top players, known for its extensive portfolio of urological products, including advanced double pigtail ureteral stents. Their focus on innovative materials and coatings has enhanced product performance, contributing to a significant share of the U.S. market. Another major player is Cook Medical Inc., which offers a wide range of stents designed to meet varied patient needs, including options for improved patient comfort and reduced complications.

C.R. Bard, now part of BD (Becton, Dickinson and Company), is also a strong competitor in this space. Bard's long history in urological devices and continued investment in research have helped maintain its position as a trusted supplier of double pigtail ureteral stents. Teleflex Incorporated rounds out the list of key U.S. market players with its focus on high-quality stent designs and expanding presence across hospital and outpatient settings.

Globally, the market is more diverse with multinational corporations and regional manufacturers playing significant roles. Medtronic plc is a major global player with a broad product range that includes double pigtail ureteral stents. Known for its innovation and wide-reaching distribution, Medtronic captures a substantial portion of the global market. Olympus Corporation, while primarily recognized for medical imaging and surgical devices, is also an important supplier of ureteral stents internationally, especially in markets where minimally invasive procedures are rapidly growing.

European-based Coloplast Corp has gained global recognition for its patient-centric approach, developing stents that emphasize ease of use and patient comfort. Meanwhile, companies like Allium Medical Solutions and Pnn Medical, though smaller, have made notable advances through innovative product designs such as drug-eluting and biodegradable stents that target niche clinical needs.

In addition to these established players, emerging companies from Asia-Pacific regions are increasingly influencing the global market. Manufacturers in countries like China and India are expanding their reach by offering cost-effective alternatives, appealing to price-sensitive markets with growing healthcare infrastructure.

Market dynamics are heavily influenced by continuous technological innovation. Key players invest in developing stents with enhanced materials that reduce encrustation, improve biocompatibility, and increase dwell times without discomfort. These advances help differentiate products and maintain competitive advantages. Furthermore, the rising adoption of minimally invasive urological procedures worldwide boosts the demand for these stents, reinforcing the market position of leading companies.

In terms of market share, the United States accounts for a significant portion of the global demand due to its advanced healthcare infrastructure and high prevalence of urological conditions. However, the Asia-Pacific and European regions are rapidly closing the gap, driven by increasing awareness and healthcare investments.

Key Questions Answered in the Double Pigtail Ureteral Stent market report:

What is the total global and United States Double Pigtail Ureteral Stent Sales volume, and how has it changed over the past five years?

What is Double Pigtail Ureteral Stent price trend, what has been the historical prices in United States and other countries?

What will be the Double Pigtail Ureteral Stent price trend in 2025?

United States Double Pigtail Ureteral Stent Sales, and what factors contribute to their dominance in the market?

How does Double Pigtail Ureteral Stent Sales vary across key manufacturers, and what expansions have been observed recently?

What is the revenue generated from Double Pigtail Ureteral Stent Sales, and how does it compare to previous years, in the United States and other parts of the world?

Which industries drive the highest demand for Double Pigtail Ureteral Stent, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Double Pigtail Ureteral Stent Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Double Pigtail Ureteral Stent Sales and market dynamics?

Related Studies:

Variable Length Ureteral Stent Market
https://datavagyanik.com/reports/variable-length-ureteral-stent-market/

Metallic Ureteral Stents Market
https://datavagyanik.com/reports/metallic-ureteral-stents-market/

Loop Ureteral Stents Market
https://datavagyanik.com/reports/loop-ureteral-stents-market/

Medical device hydrophilic coating Market
https://datavagyanik.com/reports/medical-device-hydrophilic-coating-market/

Female External Catheter Kit Market
https://datavagyanik.com/reports/female-external-catheter-kit-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.